Munich - Delayed Quote EUR
Corcept Therapeutics Inc (HTD.MU)
As of 8:02 AM GMT+2. Market Open.
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
28.0
ESG Risk Score for Peers
Name | Total ESG Risk score | E | S | G |
---|---|---|---|---|
YMAB Y-mAbs Therapeutics, Inc. | 28 | -- | -- | -- |
BLE.MU BLUEBIRD BIO INC. DL-,01 | 28 | -- | -- | -- |
HTD.MU CORCEPT THERAPEUTICS INC. | 28 | -- | -- | -- |
1FG.SG FibroGen Inc. | 28 | -- | -- | -- |
EWTX Edgewise Therapeutics, Inc. | 28 | -- | -- | -- |
Controversy Level Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are rated on a scale from one to five with five denoting the most serious controversies with the largest potential impact.
Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are rated on a scale from one to five with five denoting the most serious controversies with the largest potential impact.
ESG data provided by Sustainalytics, Inc. Last Updated on 10/2024
HTD.MU
Category Average
1 Low Controversy Level
None 4 Severe
1.0 HTD.MU
0.4 Category Average
Product Involvement Areas Flags a company’s involvement in products, services and business activities commonly used for screening purposes.
Flags a company’s involvement in products, services and business activities commonly used for screening purposes.
Products and Activities | Significant Involvement |
---|---|
Alcoholic Beverages | No |
Adult Entertainment | No |
Gambling | No |
Tobacco Products | No |
Animal Testing | Yes |
Fur and Specialty Leather | No |
Controversial Weapons | No |
Small Arms | No |
Catholic Values | No |
GMO | No |
Military Contracting | No |
Pesticides | No |
Thermal Coal | No |
Palm Oil | No |
Related Tickers
1VT.F Viking Therapeutics, Inc.
58.50
-1.18%
IVA.PA Inventiva S.A.
2.6350
+0.19%
SGMT Sagimet Biosciences Inc.
5.78
+3.77%
GMAB Genmab A/S
22.65
-0.59%
REGN Regeneron Pharmaceuticals, Inc.
968.29
-0.02%
NOVO-B.CO Novo Nordisk A/S
801.00
-0.82%
VRTX Vertex Pharmaceuticals Incorporated
475.79
-0.48%
MRNA Moderna, Inc.
53.09
-1.32%